Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

ClinicalTrials.gov ID: NCT00360490

Public ClinicalTrials.gov record NCT00360490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open Label, Parallel Group, Active Control Study to Evaluate the Efficacy and Safety of LNG IUS (Mirena®) as Compared to Medroxyprogesterone Acetate During 6 Cycles of Treatment in Patients With Idiopathic Menorrhagia

Study identification

NCT ID
NCT00360490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
165 participants

Conditions and interventions

Conditions

Interventions

  • Levonorgestrel IUS (Mirena, BAY86-5028) Drug
  • Medroxyprogesterone acetate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
Dec 8, 2013

2006 – 2008

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Not listed Tucson Arizona 85712
Not listed Beverly Hills California 90211
Not listed Carmichael California 95608
Not listed San Diego California 92103
Not listed San Diego California 92108
Not listed Santa Monica California 90403
Not listed Torrance California 90509
Not listed Littleton Colorado 80122
Not listed Boynton Beach Florida 33437
Not listed Jacksonville Florida 32216
Not listed West Palm Beach Florida 33409
Not listed Boise Idaho 83702
Not listed Chicago Illinois 60612
Not listed Newburgh Indiana 47630
Not listed South Bend Indiana 46601
Not listed Amite Louisiana 70422
Not listed Marrero Louisiana 70072
Not listed Boston Massachusetts 02118
Not listed Saginaw Michigan 48602
Not listed Chesterfield Missouri 63017
Not listed Lincoln Nebraska 68510
Not listed Las Vegas Nevada
Not listed LasVegas Nevada 89106
Not listed Moorestown New Jersey 08057
Not listed New Brunswick New Jersey 08901
Not listed Winston-Salem North Carolina 27103
Not listed Medford Oregon 97504
Not listed Portland Oregon 97239
Not listed Philadelphia Pennsylvania 19114
Not listed Pittsburgh Pennsylvania 15206
Not listed Columbia South Carolina 29201
Not listed Clarksville Tennessee 37043
Not listed Houston Texas 77030
Not listed Houston Texas
Not listed Burlington Vermont 05401
Not listed Norfolk Virginia 23507
Not listed Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00360490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2013 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00360490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →